PP
BVS icon

PDT Partners’s Bioventus BVS Stock Holding History

PDT Partners’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$398K Hold
42,113
– – 0.02% 422
2026
Q1 		$384K Sell
42,113
-13,116
-24% -$110K 0.02% 440
2025
Q4 		$411K Hold
55,229
– – 0.03% 447
2025
Q3 		$369K Hold
55,229
– – 0.02% 483
2025
Q2 		$366K Buy
55,229
+42,072
+320% +$298K 0.02% 567
2025
Q1 		$120K Buy
+13,157
New +$131K 0.01% 713

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PDT Partners's BVS Position: Q2 2026 in Review

PDT Partners held its Bioventus (BVS) position steady in Q2 2026 at 42,113 shares worth $398K. The position accounts for 0.02% of the portfolio, ranked #422.

PDT Partners first reported a position in BVS in Q1 2025 and has held it in 6 quarters since. The position peaked at $411K in Q4 2025. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • PDT Partners held 42,113 shares of Bioventus worth $398K as of Q2 2026.
  • PDT Partners left its Bioventus share count unchanged in Q2 2026.
  • Bioventus made up 0.02% of PDT Partners's portfolio in Q2 2026, its #422 holding.
  • PDT Partners first reported a position in Bioventus in Q1 2025 and has held it in 6 quarters since.
  • PDT Partners's Bioventus position peaked at $411K in Q4 2025.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.